Wednesday, May 8, 2013

Psychiatry in Crisis! Mental Health Director Rejects Psychiatric “Bible” and Replaces with… Nothing - By John Horgan - blogs.scientificamerican.com

 

Psychiatry in Crisis! Mental Health Director Rejects Psychiatric “Bible” and Replaces with… Nothing

ADVERTISEMENT
What is mental illness? Schizophrenia? Autism? Bipolar disorder? Depression? Since the 1950s, the profession of psychiatry has attempted to provide definitive answers to these questions in the Diagnostic and Statistical Manual of Mental Disorders. Often called The Bible of psychiatry, the DSM serves as the ultimate authority for diagnosis, treatment and insurance coverage of mental illness.
Now, in a move sure to rock psychiatry, psychology and other fields that address mental illness, the director of the National Institutes of Mental Health has announced that the federal agency–which provides grants for research on mental illness–will be “re-orienting its research away from DSM categories.” Thomas Insel’s statement comes just weeks before the scheduled publication of the DSM-V, the fifth edition of the Diagnostic and Statistical Manual. Insel writes:
“While DSM has been described as a ‘Bible’ for the field, it is, at best, a dictionary, creating a set of labels and defining each. The strength of each of the editions of DSM has been ‘reliability’–each edition has ensured that clinicians use the same terms in the same ways. The weakness is its lack of validity. Unlike our definitions of ischemic heart disease, lymphoma, or AIDS, the DSM diagnoses are based on a consensus about clusters of clinical symptoms, not any objective laboratory measure. In the rest of medicine, this would be equivalent to creating diagnostic systems based on the nature of chest pain or the quality of fever. Indeed, symptom-based diagnosis, once common in other areas of medicine, has been largely replaced in the past half century as we have understood that symptoms alone rarely indicate the best choice of treatment. Patients with mental disorders deserve better.”
Insel said that the NIMH will be replacing the DSM with the “Research Domain Criteria (RDoC),” which define mental disorders based not just on vague symptomology but on more specific genetic, neural and cognitive data. But then, immediately after making this dramatic announcement, Insel added that “we cannot design a system based on biomarkers or cognitive performance because we lack the data.”
Hunh? So the NIMH is replacing the DSM definitions of mental disorders, which virtually everyone agrees are profoundly flawed, with definitions that even he admits don’t exist yet! What more evidence do we need that modern psychiatry is in a profound state of crisis?
Insel’s statement is also an implicit admission that there is no real theoretical basis for drug treatments for mental illness. As I have pointed out previously, drug treatments have surged over the past few decades, while rates of mental illness, far from falling, have risen.
Ironically, some pharmaceutical companies that have enriched themselves by selling psychiatric drugs are now cutting back on further research on mental illness. The “withdrawal” of drug companies from psychiatry, Steven Hyman, a psychiatrist and neuroscientist at Harvard and former NIMH director, wrote last month, “reflects a widely shared view that the underlying science remains immature and that therapeutic development in psychiatry is simply too difficult and too risky.” Funny how this view isn’t incorporated into ads for antidepressants and antipsychotics.
NIMH director Insel doesn’t mention it, but I bet his DSM decision is related to the big new Brain Initiative, to which Obama has pledged $100 million next year. Insel, I suspect, is hoping to form an alliance with neuroscience, which now seems to have more political clout than psychiatry. But as I pointed out in posts here and here on the Brain Initiative, neuroscience still lacks an overarching paradigm; it resembles genetics before the discovery of the double helix.
Since I became a science writer 30 years ago, I have heard countless claims about breakthroughs in our understanding and treatment of mental illness. And yet as the NIMH decision on the DSM indicates, the science of mental illness is still appallingly primitive. Instead of forming fancy new programs and initiatives and alliances, leaders in mental health should perhaps do some humble, honest soul searching before they decide how to proceed. And they should think of what’s best not for their professions or the pharmaceutical industry but for those suffering from mental illness, who deserve better.
Photo: http://www.tumblr.com/tagged/dsm-iv-tr.
About the Author: Every week, hockey-playing science writer John Horgan takes a puckish, provocative look at breaking science. A teacher at Stevens Institute of Technology, Horgan is the author of four books, including The End of Science (Addison Wesley, 1996) and The End of War (McSweeney's, 2012). Follow on Twitter@Horganism.
The views expressed are those of the author and are not necessarily those of Scientific American.

NIMH | Director’s Blog WED MAY 8TH, 2013 - THOMAS INSEL Transforming Diagnosis


Transforming Diagnosis
SHARED BY 1 PERSON
Director’s Blog
In a few weeks, the American Psychiatric Association will release its new edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). This volume will tweak several current diagnostic categories, from autism spectrum disorders to mood disorders. While many of these changes have been contentious, the final product involves mostly modest alterations of the previous edition, based on new insights emerging from research since 1990 when DSM-IV was published. Sometimes this research recommended new categories (e.g., mood dysregulation disorder) or that previous categories could be dropped (e.g., Asperger’s syndrome).1
The goal of this new manual, as with all previous editions, is to provide a common language for describing psychopathology. While DSM has been described as a “Bible” for the field, it is, at best, a dictionary, creating a set of labels and defining each. The strength of each of the editions of DSM has been “reliability” – each edition has ensured that clinicians use the same terms in the same ways. The weakness is its lack of validity. Unlike our definitions of ischemic heart disease, lymphoma, or AIDS, the DSM diagnoses are based on a consensus about clusters of clinical symptoms, not any objective laboratory measure. In the rest of medicine, this would be equivalent to creating diagnostic systems based on the nature of chest pain or the quality of fever. Indeed, symptom-based diagnosis, once common in other areas of medicine, has been largely replaced in the past half century as we have understood that symptoms alone rarely indicate the best choice of treatment.
Patients with mental disorders deserve better. NIMH has launched the Research Domain Criteria (RDoC) project to transform diagnosis by incorporating genetics, imaging, cognitive science, and other levels of information to lay the foundation for a new classification system. Through a series of workshops over the past 18 months, we have tried to define several major categories for a new nosology (see below). This approach began with several assumptions:
  • A diagnostic approach based on the biology as well as the symptoms must not be constrained by the current DSM categories,
  • Mental disorders are biological disorders involving brain circuits that implicate specific domains of cognition, emotion, or behavior,
  • Each level of analysis needs to be understood across a dimension of function,
  • Mapping the cognitive, circuit, and genetic aspects of mental disorders will yield new and better targets for treatment.
It became immediately clear that we cannot design a system based on biomarkers or cognitive performance because we lack the data. In this sense, RDoC is a framework for collecting the data needed for a new nosology. But it is critical to realize that we cannot succeed if we use DSM categories as the “gold standard.”2 The diagnostic system has to be based on the emerging research data, not on the current symptom-based categories. Imagine deciding that EKGs were not useful because many patients with chest pain did not have EKG changes. That is what we have been doing for decades when we reject a biomarker because it does not detect a DSM category. We need to begin collecting the genetic, imaging, physiologic, and cognitive data to see how all the data – not just the symptoms – cluster and how these clusters relate to treatment response.
That is why NIMH will be re-orienting its research away from DSM categories. Going forward, we will be supporting research projects that look across current categories – or sub-divide current categories – to begin to develop a better system. What does this mean for applicants? Clinical trials might study all patients in a mood clinic rather than those meeting strict major depressive disorder criteria. Studies of biomarkers for “depression” might begin by looking across many disorders with anhedonia or emotional appraisal bias or psychomotor retardation to understand the circuitry underlying these symptoms. What does this mean for patients? We are committed to new and better treatments, but we feel this will only happen by developing a more precise diagnostic system. The best reason to develop RDoC is to seek better outcomes.
RDoC, for now, is a research framework, not a clinical tool. This is a decade-long project that is just beginning. Many NIMH researchers, already stressed by budget cuts and tough competition for research funding, will not welcome this change. Some will see RDoC as an academic exercise divorced from clinical practice. But patients and families should welcome this change as a first step towards "precision medicine,” the movement that has transformed cancer diagnosis and treatment. RDoC is nothing less than a plan to transform clinical practice by bringing a new generation of research to inform how we diagnose and treat mental disorders. As two eminent psychiatric geneticists recently concluded, “At the end of the 19th century, it was logical to use a simple diagnostic approach that offered reasonable prognostic validity. At the beginning of the 21st century, we must set our sights higher.”3
The major RDoC research domains:
Negative Valence Systems
Positive Valence Systems
Cognitive Systems
Systems for Social Processes
Arousal/Modulatory Systems

References

1Mental health: On the spectrum. Adam D. Nature. 2013 Apr 25;496(7446):416-8. doi: 10.1038/496416a. No abstract available. PMID: 23619674
2Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Kapur S, Phillips AG, Insel TR. Mol Psychiatry. 2012 Dec;17(12):1174-9. doi: 10.1038/mp.2012.105. Epub 2012 Aug 7.PMID:22869033
3The Kraepelinian dichotomy - going, going... but still not gone. Craddock N, Owen MJ. Br J Psychiatry. 2010 Feb;196(2):92-5. doi: 10.1192/bjp.bp.109.073429. PMID: 20118450

Learn more about: NIMH. View all posts about: NIMH.
READ THE WHOLE STORY
· · ·
Why Psychiatry's Seismic Shift Will Happen Slowly
SHARED BY 1 PERSON
Changing how patients with mental illness are diagnosed is going to take a lot longer than many people seem to think.

Why Psychiatry's Seismic Shift Will Happen Slowly - 5/8/2013 - Forbes - Business

Why Psychiatry's Seismic Shift Will Happen Slowly - 5/8/2013 - Forbes - Business

» Why Psychiatry's Seismic Shift Will Happen Slowly
08/05/13 08:43 from Forbes - Tech
Last week, Thomas Insel, Director of the National Institute of Mental Health, published a blog post that outlined a new approach for deciding what psychiatry research the U.S. government would fund. No longer, he wrote, would the NIMH rely ..



Matthew Herper
Matthew Herper, Forbes Staff
I cover science and medicine, and believe this is biology's century.
PHARMA & HEALTHCARE 
|
 
5/08/2013 @ 9:43AM |2,000 views

Why Psychiatry's Seismic Shift Will Happen Slowly

English: official picture of Thomas R. Insel, ...
Thomas R. Insel, Director, National Institute of Mental Health. (Photo credit: Wikipedia)
Last week, Thomas Insel, Director of the National Institute of Mental Health, published a blog post that outlined a new approach for deciding what psychiatry research the U.S. government would fund. No longer, he wrote, would the NIMH rely on the Diagnostic and Statistical Manual of Mental Disorders, the collection of symptoms used by psychiatrists to diagnose depression, bipolar disorder, schizophrenia, and other ailments, as its “gold standard” for categorizing patients in research studies. He wrote:
While DSM has been described as a “Bible” for the field, it is, at best, a dictionary, creating a set of labels and defining each. The strength of each of the editions of DSM has been “reliability” – each edition has ensured that clinicians use the same terms in the same ways. The weakness is its lack of validity. Unlike our definitions of ischemic heart disease, lymphoma, or AIDS, the DSM diagnoses are based on a consensus about clusters of clinical symptoms, not any objective laboratory measure. In the rest of medicine, this would be equivalent to creating diagnostic systems based on the nature of chest pain or the quality of fever. Indeed, symptom-based diagnosis, once common in other areas of medicine, has been largely replaced in the past half century as we have understood that symptoms alone rarely indicate the best choice of treatment.
As a result of this, he wrote, the NIMH “will be re-orienting its research away from DSM categories.” Instead, it would be encouraging medical researchers to frame their studies using a still nascent classification system being developed by the NIMH, called RDoC.
The reaction from the blogosphere was swift and loud as journalists and bloggers interpreted the decision as a swipe against the fifth edition of the DSM (called the DSM-5) and the American Psychiatric Association, which compiles it. Mindhacks wrote that the NIMH was “abandoning the DSM” and called the move “potentially seismic.” New Scientist called it a “bombshell” and said the DSM was being “denounced.” The Verge also went with the headline that the NIMH was abandoning the “controversial bible” of psychiatry.  John Horgan at Scientific American wrote that psychiatry was in crisis as Insel rejected its Bible and replaced it with nothing.
There were also some more nuanced comments, from Neurocritic and 1 Boring Old Man, noting that this was not a shift so much as a continuation of the line of thinking that had been presented previously by both Insel and the APA itself. But the DSM-5 has been beset by controversy, partly because Allen Frances, a prominent psychiatrist who worked on previous editions, has been publicly decrying the way the new edition of the manual was put together. And a fight between the country’s largest psychiatric organization and the institute that decides which psychiatric projects get government money was too good to pass up.
The real story is more complex, and it is driven by the huge disappointments of the past two decades in psychiatric research, which have failed to lead to new drugs and have led to most large drug companies backing away from or abandoning the psychiatric field. Changing how patients with mental illness are diagnosed is going to take a lot longer than many people seem to think. The DSM is not being abandoned — psychiatry is finally growing up.
I called the NIMH, and was put on the phone with Bruce Cuthbert, the director of the division of adult translational research. I had a pretty simple question. If the NIMH were really rejecting or abandoning the DSM, that would mean the agency wouldn’t accept studies that use DSM-5 criteria. For instance, if you wanted to test a new schizophrenia drug in schizophrenics, you’d have to find some new RDoC way of describing the disease.
Cuthbert said repeatedly that would not be the case. It’s not so much that studies that use the DSM-5 will be excluded and abandoned, but that researchers would now be allowed to apply for grants that would not use the manual’s diagnostic criteria, or subdivided them in new, creative ways.
“Using DSM diagnoses for research has become a de facto standard ever since the DSM-III came out in 1980,” Cuthbert said. “What we are trying to do is to study neural systems directly because they cut across lots of the dsm disorders.” I asked the question again. “We are moving in a new direction. That doesn’t mean that next month we’ll stop accepting DSM diagnoses. It rather is a shift in emphasis.
New studies can still include DSM diagnoses, but their boundaries should not be limited by what’s in the DSM. The new NIMH policy gives scientists the choice of going much broader, or being far more narrow.
In practice, grants at the NIMH are given out by a peer review scoring system in which anonymous experts critique proposals. At the end of the day, which grants get funded will depend on how they do in that system. So this change in focus will happen slowly, and will depend on the exact experiment being done.
The DSM-5 will still be the manual used by psychiatrists diagnosing patients, and it will still be used by insurance companies, and the government programs Medicare and Medicaid to decide what to pay doctors and hospitals for treating mentally ill patients. Cuthbert says that the NIMH is already working on ways to build “crosswalks” between the DSM-V and its new RdoC diagnosis system, which is still barely sketched out.
Why change at all? Cuthbert gives the example of one symptom of depression called anhedonia, the scientific name for inability to find pleasure in normally enjoyable activities. On the one hand, this condition occurs in lots of psychiatric illnesses, including anxiety and eating disorders. We don’t know if it is neurologically similar in all of them or not. On the other hand, there are different types of anhedonia, Cuthbert says. Some people might go out to dinner with friends and not enjoy it. Others might be so down as to lack the energy to get to the restaurant in the first place, even though they would enjoy it once they arrived.
The NIMH’s strategy with the RDoC approach is to dis-entangle a diagnosis like this. If there were a protein or blood test or brain scan that fit with one type of anhedonia (people with eating disorders who are too tired to go out for instance), but not with the others, it doesn’t want to miss it. But this means taking the DSM-5 apart and re-assembling it through arduous experimental work. “It’s going to take a decade or more for results to bear fruit,” Cuthbert says.
The idea that psychiatry needs to become more focused on biological causes of disease, not associations of symptoms, is not new, either for Insel, who gave a TEDex talk on the topic, or to psychiatry as a whole. A recent paper in The Lancet, a medical journal, found that schizophrenia, bipolar disorder, autism, major depression and attention deficit hyperactivity disorder all shared common genetic glitches as potential causes.
Behind all this talk about biology is a commercial reality: psychiatric drug development has become a dead-end. GlaxoSmithKline, Novartis, and AstraZeneca have stopped trying to invent new psychiatric drugs. Pfizer, Merck, and Sanofi have de-emphasized them. There are just 303 psychiatric drugs in development, compared to 3,436 cancer medicines and 1,247 drugs for other neurological disorders, according to the Analysis Group in a study commissioned by PhRMA, the drug industry trade group.
The introduction of the DSM-III in 1980 created a standardized language for psychiatry, and this did lead to big advances in psychiatric medicine. The next decade would see the introduction of anti-depressants like Prozac, Paxil and Wellbutrin and antipsychotic drugs like Zyprexa, Risperdal, and Abilify. In the 2000s, the NIMH funded big, independent clinical trials testing how well these medicines compared and how well to use them. A big study of the antidepressants found that a third of patients became symptom-free on taking them, but that switching those who were not helped to other drugs yielded diminishing results. A study of the schizophrenia drugs showed that, for just about all of them, patients and doctors chose to switch to another treatment three-quarters of the time, showing how difficult to use these medicines are.
But the strategy of conducting studies of existing drugs in thousands of patients fails when new drugs are not being invented. So Cuthbert says that the NIMH is very consciously focusing on small studies of new experimental drugs that drug companies have not embraced. The idea is to follow the “de-risking” model that has been successful for disease charities. The best example is Kalydeco, a drug for cystic fibrosis originally developed at Vertex Pharmaceuticals with funding from the Cystic Fibrosis Foundation. Eventually the drug became Vertex’s most important product, demanding lots of resources and generating a high price. The idea is to try to get industry interested in psychiatry again. Changing the diagnostic system, seen as one reason that drugs are failing, is part of the job.
Jeffrey Lieberman, the chairman of psychiatry at Columbia University’s College of Physicians and Surgeons, ran the NIMH’s big schizophrenia trial. He is also a defender of the DSM in its current form. But he is also a big believer that psychiatry needs to base its decisions more on biology, and less on behavior.
“The DSM is the past and, for the time being, the present,” says Lieberman. “But it won’t be the future. The future it will be either improved or replaced by a more physiologically based set of diagnostic criteria. That may change the whole landscape for diagnosis.”

Tuesday, May 7, 2013

Pentagon Study Finds Sharp Rise in Military Sexual Assaults - New York Times

» Pentagon Study Finds Sharp Rise in Military Sexual Assaults - New York Times
07/05/13 20:21 from Top Stories - Google News
ABC News Pentagon Study Finds Sharp Rise in Military Sexual Assaults New York Times WASHINGTON — The problem of sexual assault in the military came into unsparing focus on Tuesday as the Pentagon released a study estimating that 26,000 peo..

The number of suicides among middle-aged Americans rose by 28 percent this past decade, according to the U.S. Centers for Disease Control and Prevention


The number of suicides among middle-aged Americans rose by 28 percent this past decade, according to the U.S. Centers for Disease Control and Prevention. The rate among whites is even more startling: A 40 percent increase in suicides from 1999 to 2010 among the age group 35 to 64. One theory blames the long economic recession. However, in the same period, suicide rates for younger and older people did not change, and there was little change in the rate among middle-aged blacks and Hispanics. (Suicide was the 10th leading cause of death nationwide among people 10 and over in 2009, accounting for 36,891 deaths, the CDC says, making it a greater health risk than hypertension, liver disease, HIV, Parkinson's, and homicide). At the same time, some are saying depression, a key cause, is mis-diagnosed or over-diagnosed. Why are more middle-aged Americans killing themselves?

http://yhoo.it/132CrbA
The number of suicides among middle-aged Americans rose by 28 percent this past decade, according to the U.S. Centers for Disease Control and Prevention. The rate among whites is even more startling: A 40 percent increase in suicides from 1999 to 2010 among the age group 35 to 64. One theory blames the long economic recession. However, in the same period, suicide rates for younger and older people did not change, and there was little change in the rate among middle-aged blacks and Hispanics. (Suicide was the 10th leading cause of death nationwide among people 10 and over in 2009, accounting for 36,891 deaths, the CDC says, making it a greater health risk than hypertension, liver disease, HIV, Parkinson's, and homicide). At the same time, some are saying depression, a key cause, is mis-diagnosed or over-diagnosed. Why are more middle-aged Americans killing themselves?

http://yhoo.it/132CrbA

Hagel: 'Outrage, disgust' as Air Force leader charged with sexual battery - CNN


Hagel: 'Outrage, disgust' as Air Force leader charged with sexual battery

From Barbara Starr and Greg Seaby, CNN
May 7, 2013 -- Updated 0236 GMT (1036 HKT)

Sunday, April 21, 2013

4.21.13 - Discussions on the issues of Diagnosis in Psychiatry

Discussions on the issues of Diagnosis in Psychiatry



Links and References

-


What's Normal? What's Not?

By Allen Frances, MD | April 1, 2013
Twitter: @AllenFrancesMD

The liveliest debate in psychiatry today is where to draw the line between mental disorder and mental health. So much rides on the decision—who gets treated and how, who pays for it, whether a criminal is deemed mad or bad, whether someone gets damages in tort cases, who qualifies for disability payments and eligibility for extra school services, whether someone can adopt a child—and there's a whole lot more.
But here is the big problem. No bright line marks the boundary between illness and health. At the extremes, it is easy to diagnose mental illness accurately and to distinguish it from normality. At the fuzzy border, it is impossible.
This is true now and will remain true into the distant future—until we finally have biological tests in psychiatry. In a few years, there will be lab tests for Alzheimer's, but the pipeline for the other disorders is dry.
The problem with precisely defining “normal” has been recognized almost since the beginning of psychiatry as a separate profession in the 19th century. Peter Kinderman, the British psychologist who has become one of the leaders in opposition to DSM-5, has unearthed two wonderful quotes from 150 years ago that state the issue much more eloquently than anything that has been written since.
The first comes from an editorial in the London Times, from Saturday, July 22, 1854:
“Nothing can be more slightly defined than the line of demarcation between sanity and insanity. Physicians and lawyers have vexed themselves with attempts at definitions in a case where definition is impossible. There has never yet been given to the world anything in the shape of a formula upon this subject, which may not be torn to shreds in five minutes by any ordinary logician. Make the definition too narrow, it becomes meaningless; make it too wide, the whole human race are involved in the drag-net. In strictness, we are all mad as often as we give way to passion, to prejudice, to vice, to vanity; but if all the passionate, prejudiced, vicious, and vain people in this world are to be locked up as lunatics, who is to keep the keys to the asylum?”
The second equally telling quote is from the 1888 novella, “Billy Budd” by Herman Melville:
“Who in the rainbow can draw the line where the violet tint ends and the orange tint begins? Distinctly we see the difference of the colors, but where exactly does the one first blendingly enter into the other? So with sanity and insanity. In pronounced cases there is no question about them. But in some supposed cases, in various degrees supposedly less pronounced, to draw the exact line of demarcation few will undertake tho' for a fee some professional experts will. There is nothing namable but that some men will undertake to do it for pay.”
Victorian writing has a subtlety and grace of expression rarely found in our more utilitarian modern modes of speech. But the puzzle of defining the boundary between normal and illness is just as problematic today as it was then.
Decisions on where to draw the line must necessarily rest not on any abstract definition that clearly separates the two, but rather on practical consequences. Will including a new disorder in DSM, or changing the threshold for an existing one, result in more harm or more good?
This is a brass standard, but will have to do in the absence of a gold one. Clearly, we currently have an imbalance. Loose definitions, and even looser application of them under the pressure of pharma marketing, have expanded psychiatry beyond its competence and have made normal an endangered species.
It is time for a correction back to a reasonable Goldilocks balance. To get there, we need a tighter diagnostic system and an end to pharma marketing.
Let's close with one final great quote, this time from Isaac Newton: “I can calculate the motions of the heavens, but not the madness of men.” We can't do a very precise job of this either, but we can certainly do a lot better than we are now.


-

Psychiatry and the Myth of “Medicalization”

By Ronald W. Pies, MD | April 18, 2013

DSM-5, ethicsWhatever happened to common sense? You know what I mean—these psychiatrists medicalize every ordinary feeling and behavior, every normal stress and strain of living. Why, the way they want to call ordinary shyness “Social Anxiety Disorder,” or ordinary grief “Major Depressive Disorder”—it’s ridiculous! These so-called diagnoses are just false positives—not cases of disease or disorder. These self-appointed experts keep invading the territory of normal human experience like conquistadors! Then they prescribe all kinds of harmful medications for nonexistent diseases. And now, they are expanding their diagnostic system, to the point where nobody is normal anymore!
Are any of these claims even controversial these days? Even for some readers ofPsychiatric Times, I suspect not. After all, we have heard this line of argument from respected academics; many patients, or consumers; some of psychiatry’s own luminaries; and many sincere and conscientious clinicians. Recently, one particularly renowned critic pointed to the “diagnostic imperialism” of DSM.1 Indeed, before the final text of DSM-5 has even appeared, several books criticizing the manual have been published or are soon to be published.
But does this narrative of psychiatry’s medicalization of normality really represent common senseor is it mostly common nonsense? In my view, the medicalization narrative contains some kernels of truth, and many defenders of the term proceed from honorable and well-intentioned motives; for example, the wish to reduce unnecessary use of psychotropic medication—and who could be opposed to that? But on the whole, I believe the medicalization narrative is philosophically naive and clinically unhelpful. On close examination, the term “medicalization” proves to be largely a rhetorical device, aimed at ginning up popular opposition to psychiatric diagnosis. It not only stigmatizes the field of psychiatry and those who practice in it, but it also undermines our ability to provide the best care to our patients, by spuriously normalizing their suffering and incapacity.2
I am not claiming that careless diagnosis and over-diagnosis never occur in psychiatry. Alas, as in all of medicine, sometimes they do—particularly when insufficient time is allowed for the initial evaluation of the patient, and when no validated scales or screening instruments are used.3 (Under-diagnosis also occurs, as in the failure to recognize MDD in some settings—but that’s another story.4) Neither am I voicing a full-throated defense of the DSM-5 manual. Indeed, while I respect the good-faith efforts of the framers of DSM-5, I have serious concerns regarding some of their decisions, such as lowering the threshold for the diagnosis of somatoform disorders (now called Somatic Symptom Disorders).1
What I do want to claim is that when a psychiatric diagnosis is accurately and carefully made, according to generally accepted (eg, DSM or ICD) criteria, it should not be normalized or declared non-disordered because its manifestation is understandable or explained by the psychosocial context in which it occurs—or because it is deemed proportionate to some hypothetical evolved mechanism.5
The normality fallacy
For the proposition “psychiatry is medicalizing normality” to be true, we would need (a) adequate definitions of the terms “medicalizing” and “normality” and (b) convincing evidence that psychiatry is actually doing what the proposition asserts. Yet both required elements of truth turn out to be complex and problematic. For one thing, psychiatry’s critics almost never bother to define the terms “medicalizing” and “normality.” (Does medicalization refer to application of the medical model, or to the use of medication? And what is the medical model, exactly? Is normality a purely statistical term? Is it used in relation to a particular cultural subgroup, to the human species as a whole, or to the particular patient’s usual state of affairs?)
Moreover, those who argue that psychiatry medicalizes normality while simultaneously asserting that there is no clear demarcation between normality and abnormality effectively refute their own argument.6 For if there are no absolute, categorical boundaries separating normal from abnormal, then the claim “psychiatry is medicalizing normality” cannot logically be sustained: the argument is devoured by its own premise. That is: if normality has no precise boundary in the realm of disease—including psychiatric disease—then there can be no verifiable medicalization of normality. Neither can there be a veridical demonstration of psychiatry’s alleged diagnostic imperialism or its supposed creation of diagnostic false positives. Such claims are no more verifiable than a landowner’s complaint that someone has impermissibly planted a tree on his property, when there are no clearly established property lines. But let’s be clear: this doesn’t mean that we can’t make reasoned, empirically grounded judgments as to what conditions merit medical evaluation or treatment.
Psychiatry’s ethical aim is the relief of suffering and incapacity
So long as the patient is experiencing a substantial or enduring state of suffering and incapacity, the patient has disease (dis-ease).5 To assert this is not to medicalize normality, but to affirm what physicians have recognized as an ethical imperative, for millennia: the need to relieve the misery of the patient. Indeed, as Prof H. C. Erik Midelfort, Professor of History at the University of Virginia and author of A History of Madness in Sixteenth-Century Germany,comments:
. . . for ancient and early modern physicians, there was no clear, bright line between disease and health. They did not, generally, decide that someone was suffering an understandable and proportionate sadness and was not therefore “ill.” They generally decided that if one were suffering, for whatever reason and whether proportionate or disproportionate, they would do what they could to help . . . [and their remedies] did not depend upon a strict decision that so-and-so was fundamentally “ill” while someone else was merely sad for good, sufficient, and proportionate reasons. (E. Midelfort, personal communications, October 2008 and March 2012.)
Indeed, as historian and Psychiatric Times blogger Prof Greg Eghigian7 has commented:
Midelfort get[s] at something important that many commentators on the history of psychiatry often either ignore or consider unimportant: the fact that the overwhelming majority of patients treated by psychiatrists, “mad-doctors,” mental healers, etc, over the centuries have presented symptoms clearly crossing the “threshold of chronicity or severity.” And indeed, this is one of the reasons why I have problems with the way in which self-identifying critics of psychiatry invoke the term “medicalization”—they more often than not neglect theextraordinary and painful nature of the maladies . . . [patients] were/are facing.7
Prof Eghigian leads us toward a critical insight: the obsessive debate about what is or is not normal is largely a distraction from 2 practical issues facing all physicians:
• What is the threshold for considering a condition a disease or disorder?
• How can we best help the patient?
As a practical matter, internists do not consider an upset stomach as crossing the threshold of disease, nor do psychiatrists of any wisdom consider a mildly fidgety, bored, and inattentive child to have a disease or disorder called “ADHD.” But in both instances, these threshold decisions are based primarily on the absence of pronounced or enduring suffering and incapacity—not on an obsessive fixation on what is normal. (If common upset stomach suddenly became vanishingly rare, it still would not qualify as disease.)
Physicians, fundamentally, are not philosophers or evolutionary biologists. We do not, as a matter of daily routine, entertain metaphysical and semantic questions, such as “What is truly normal for the human species?” Rather, physicians have a general concept of what constitutes health, and a general concept of enduring and significant departures from health. We find ourselves faced with a waiting room full of distressed and often incapacitated human beings who, in ordinary circumstances, are voluntarily seeking our help. We do our best to respond to them not as specimens of abnormality, but as suffering individuals—and as fellow human beings.


-

Muddled Thinking and Psychiatric “Diagnoses”

by PHIL on FEBRUARY 23, 2013
Until just a few years ago, the spurious nature of mental illness received little or no attention either in professional circles or in the general media. There were a few of us “cranks” who poked away at the issue, but peer condemnation was usually swift and outspoken.  On one occasion I was called an “anti-science Nazi” for daring to suggest that the condition known as ADHD might have more to do with ineffective parental discipline than with brain chemistry.  We were voices in the wilderness.
Happily the landscape has changed, and today speaking out against standard psychiatry from either a theoretical or practical position is a great deal more acceptable.  A number of factors have contributed to this development.  Firstly, and I think most importantly, the APA simply went too far, too quickly.  It has always been my contention that their ultimate goal has been to embrace every conceivable human problem within their taxonomic framework.  And it has to be conceded that in this they have been very successful.  But as the proposals for DSM-5 began to emerge, there was a groundswell of resistance from various sources.  The second factor contributing to the change has been the writing of individuals who have worked tirelessly to expose the philosophical flaws and the practical abuses in modern psychiatry.  These individuals include Robert Whitaker, Christopher Lane, Daniel Carlat, all the members of the Critical Psychiatry Network, Irving Kirsch, Marcia Angell, Gary Greenberg, Steven Ray Flora, Suzy Chapman, and many others.
So today we are in the midst of a great debate on the validity and usefulness of psychiatric “diagnoses” and the appropriateness of chemical fixes for ordinary human problems.
But unfortunately, and perhaps inevitably, the debate is often derailed by vagueness and muddled thinking.  The purpose of this post is to try to clarify, or at least identify, some of the issues.
Let’s start with the question:  Is schizophrenia a mental illness?  On the face of it this looks like a fairly straightforward question, and one might imagine that people who work in the field would be able to provide an answer.  In fact, one would imagine that such a fundamental question would have been resolved decades ago.  But in fact it’s not that simple.
To illustrate the problem, let’s consider another question, this one from the field of chemistry. Is sodium hydroxide an acid or a base (alkali)?  The answer is:  It’s a base.  The reason is that an acid by definition has a pH value less than 7; a base has a pH value higher than 7; and sodium hydroxide has a pH value of 14.  The reasons that this question can be so readily resolved are:  firstly, all the terms in the question have been precisely defined; secondly, a scale exists which enables one to assess the acidity or alkalinity of any substance; and thirdly, and I suppose most importantly, chemists and other scientists have devoted an enormous amount of time and energy to the refinement of their definitions generally, and to the matter of measurement.
From this context it is easy to see the problems with the earlier question.  Before such a question can be even addressed, we need to know what we are talking about; in other words, we need definitions.
So what have we got?  The APA defines the various mental illnesses by providing a list of criteria and specifying how many have to be met to make the “diagnosis.”
Superficially, this looks like the pH scale for acidity/alkalinity mentioned above.  Under 7 – acid; over 7 – alkali.  For schizophrenia, two or more items – yes; less than 2 items – no.  (It’s a little more complicated than this, but for our present purposes this is close enough.)  But the similarity is illusory, because the pH scale reflects, and is built around, the hydrogen ion concentration which is the essence of acidity.  In other words the scale was constructed to measure what acidity and alkalinity really are.  No such claim can be made about the items on the schizophrenia scale.
The pH definition is an essential definition: it elucidates or reveals the true nature of the matter.  “Behind” the scale there is a wealth of scientific understanding.  The schizophrenia scale reveals nothing of the essence of the matter.  There is nothing substantial behind the scale.  The scale plus the cutoff number is the definition of schizophrenia.
This is important, because the APA (and psychiatrists generally) claim that their system is scientific.  But in fact their definitions don’t meet even minimal requirements of general science.
But even if we put that matter aside, there are other problems with the schizophrenia scale.  The text reads:
“A. Characteristic symptoms: Two (or more) of the following, each present for a significant portion of time during a 1-month period (or less if successfully treated):
(1)  delusions
(2)  hallucinations
(3)  disorganized speech (e.g., frequent derailment or incoherence)
(4)  grossly disorganized or catatonic behavior
(5)  negative symptoms, i.e., affective flattening, alogia, or avolition
Note: Only one Criterion A symptom is required if delusions are bizarre or hallucinations consist of a voice keeping up a running commentary on the person’s behavior or thoughts, or two or more voices conversing with each other.”
Firstly, the requirement of two or more items is arbitrary and unscientific.  Why not three? Or four?  The answer to this question is not based on anything in nature (as the number 7 is on the pH scale), but simply reflects an APAdecision.  Deciding is not the same as discovering.  The APA say they need two items – so it’s two items.  There is no other reason.  In theory the APA could “cure” approximately half of the victims of this “illness” by requiring four items instead of two!  This would be the equivalent of Earth scientists solving global warming by decreeing that normal ocean temperatures are two degrees higher than they are.
Secondly, there are 10 ways to extract two items from five (1 & 2; 1 & 3; 1 & 4;1 & 5; 2 & 3; 2 & 4; 2 & 5; 3 & 4; 3 & 5; 4 & 5), and there is no valid reason for supposing that these various permutations are really the same condition.  A person, for instance, who scores positive on items 3 and 5 might have very little in common with a person who scores positive on items 1 and 2.  But according to the APA, both individuals have the same illness.  There is no evidence to support this position.  Once again, it’s because the APA says so.
Thirdly, for an item to be scored positive it has to have been present for a significant portion of time during a 1-month period.  Here again, we have extreme arbitrariness.  Why one month?  Why not two?  Is there some essential underling reality about this condition that requires a one month time frame?  No.  It’s because the APA says so.
Fourthly, what’s a “significant” portion of time?  An hour?  A day?  A week?  Or do they mean this to be a proportion – an hour a day, say?  Or a day a week?  The manual gives no help.
Fifthly, even if these items were delineated more precisely, how in the world could you hope to get accurate data on what clients were doing months or even weeks ago?  If you were to ask me, for instance, how many hours a day have I spent writing, or talking on the phone, or arguing with my beloved spouse in the past two months, I couldn’t begin to give you anything better than a vague guess.  (Except, of course, the last item – that would be zero!)  It’s a well-established fact that we don’t recollect past events as accurately as we suppose.  So if a client or a client’s spouse tells a psychiatrist that the individual has been voicing delusional material for about half an hour a day for the past two months, how much credence can be placed in this?
Sixthly, the items themselves are vague.  What, for instance, is a delusion?  Here the APA does provide some help.  In their glossary of technical terms they define a delusion as follows:
“A false belief based on incorrect inference about external reality that is firmly sustained despite what almost everyone else believes and despite what constitutes incontrovertible and obvious proof or evidence to the contrary.”
Here we have lots of problems.  The only way that another person’s belief can be determined is through his overt behavior (including speech); but even then the inference is always tenuous.  An additional difficulty arises from the term “external reality.”  At present, I, for instance, believe that there is “…incontrovertible and obvious proof or evidence…” that: human activity is significantly raising the planet’s temperature; and that humans descended from lower species through natural selection; and that over six millions Jews and other persecuted minorities were murdered by German Nazis.  Other people (lots of them) believe that each of these statements is false.  So am I delusional or are they?  Who chooses?  If the psychiatrist is a creationist, would we evolutionists be considered delusional?  If a client says that the government is spying on him, do we know that this is false? At the present time a number of groups are protesting the use of drones over US air space on the grounds that they will infringe citizens’ privacy.  Should all these individuals be considered delusional?  And so on.  The point here is that deciding if an individual’s statements (beliefs) are false is in most areas a subjective, unscientific judgment.
With regards to delusions, it is also worth noting that the APA specifically excludes “articles of religious faith.”  This is not based on any kind of science, but rather to avoid conflict with religious groups.  If someone were to start a religion the central tenet of which were that the government is spying and compiling detailed files on all citizens, then delusional people who obsess about this issue would be instantly “cured,” provided they joined this church!
Similar criticisms can be leveled at the other items in A above (2 through 5).
So where have we gotten to?  We’re trying to make sense of the question:  Is schizophrenia a mental illness?  We’ve examined the APA’s definition of schizophrenia and find that it is descriptive rather than elucidative, which is a very serious problem because we can describe something in great detail and yet have not the slightest idea what it is.  (The rainbow is a good example.) But even if we go along with the descriptive definition, we find that it is impossible to apply with any degree of precision, and that it is riddled with arbitrariness and inconsistency.
So not only can we not say what schizophrenia is, we cannot even reliably identify which individuals belong in this category and which don’t.  And to make matters worse, the criterion items quoted above are only Part A of the APA’s definition of schizophrenia.  This is followed by B, C, D, E, and F, each of which suffers from reliability difficulties similar to those in Part A.
Part E is worth quoting:
“E. Substance/general medical condition exclusion: The disturbance is not due to the direct physiological effects of a substance (e.g., a drug of abuse, a medication) or a general medical condition.”
What this says is that if the “symptoms” stem from substance abuse or a general medical condition, a diagnosis of schizophrenia cannot be assigned.  This is particularly interesting, in that it is very widely stated in the psychiatric profession that schizophrenia (whatever that means) is a brain disease, i.e. that it is caused by neurological damage or malfunction.  But neurological damage/malfunction is a general medical condition and therefore by the APA’s own definition cannot be the cause of schizophrenia.  A problem arises here in that the term general medical condition is not defined anywhere in the DSM (or at least I’ve never been able to find a definition), but the term is used frequently in the manual in the sense of a physical pathology within the organism.  In anxiety disorder due to a general medical condition, for instance, the manual lists “neurological conditions” as one of the possible culprits.  So, to my mind at least, it is clear that the APA are specifically excluding from their definition of schizophrenia any kind of aberrant behavior that results from neurological impairment.
Back to the question:  Is schizophrenia a mental illness?
As we’ve seen, the term “schizophrenia” is beset with difficulties, but the term “mental illness” is infinitely more troublesome.  Let’s see if we can define it.  Turning to the DSM, we find, to many people’s surprise, that the term “mental illness” is not used.  Instead they use the words “mental disorder.”
This is a complicated issue with lots of history, much of which I’ve discussed elsewhere.
The first DSM (1952) used the term reaction (depressive reaction, schizophrenic reaction, etc.) to reflect the fact that the various conditions were reactions of the individual to internal and external factors.  DSM II (1968) referred to mental disorders, largely I suspect because there was not at that time a consensus among psychiatrists that all, or even any, of the conditions listed were in fact bona fide illnesses.  And the term mental disorder has stuck.  In fact, in studying the DSM one might understandably draw the conclusion that there are no mental illnesses!
But, of course, this is not how matters are perceived in the field.  In practice the terms mental disorder and mental illness are synonymous.
So for a definition of mental illness we must turn to the APA’s definition of a mental disorder.  This is given on page xxxi of DSM-IV-TR:
“… a clinically significant behavioral or psychological syndrome or pattern that occurs in an individual and that is associated with present distress (e.g., a painful symptom) or disability (i.e., impairment in one or more important areas of functioning) or with a significantly increased risk of suffering death, pain, disability or an important loss of freedom.”
It should be noted in passing that, once again, we have words like “significantly,” “important,” etc… which have to be interpreted subjectively, and inevitably introduce an element of vagueness into the definition.
So, is schizophrenia a mental illness?  Firstly, let us note that although the terms mental disorder and mental illness are used synonymously, there is nothing in the APA’s definition quoted above to suggest that we are dealing with an illnessin any conventional sense of the term.  The definition uses the phrase “clinically significant behavioral or psychological syndrome or pattern…” which sounds more like habit than illness.
But even if we let that go, and even if we ignore the problems in the definition of schizophrenia, it is clear that any significantly dysfunctional behavior will fall within the definition of a mental disorder.  To clarify this, I invite the reader to try thinking of a significantly dysfunctional habit that would not fall within this definition.  I certainly can’t think of any.  Playing car radios too loud is a mental disorder because if pursued long enough it will lead to deafness, which is a disability.  Even long-distance running is a mental disorder, because it is associated with a significantly increased risk of suffering pain!
So our question resolves into this:  Does the behavior of the vaguely defined, non-homogeneous group of individuals, embraced by the DSM’s definition of schizophrenia entail (for the individual concerned): present distress; orimpairment in one or more important areas of functioning: or  significantly increase risk of suffering death, pain, disability or an important loss of freedom?  In other words, do the vaguely defined problems of a vaguely defined group fall within the vaguely defined category which actually embraces all significant human problems?
The point is – and I apologize that it’s taken me so long to get here – that the question is nonsensical.  It’s a bit like asking:  Do witches have an evil aura which is detectable by trained witch-hunters?
In this article schizophrenia was used as an example.  Similar considerations apply to all the “diagnoses” in the APA’s manual.  The DSM system is logically and intellectually bereft.  It is pseudo-science; a house of cards constructed to expand psychiatric turf and to legitimize the administration of psychotropic drugs for virtually any human problem.
Last updated by  at .